LegalizeS.I. No. 505/2020 - Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2020
This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.
Notice of the making of this Statutory Instrument was published in
“Iris Oifigiúil” of 10th November, 2020.
I, Stephen Donnelly, Minister for Health, in exercise of the powers conferred on me by sections 4 and 5 (as amended by section 3 of the Misuse of Drugs (Amendment) Act 2016 (No. 9 of 2016)) of the Misuse of Drugs Act 1977 (No. 12 of 1977), hereby make the following regulations:
1.
These Regulations may be cited as the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2020.
2.
The Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) Regulations 2019 ( S.I. No. 262 of 2019 ) are amended by substituting for Schedule 1 (as amended by Regulation 2 of the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2019 ( S.I. No. 649 of 2019 )) the following:
“SCHEDULE 1
Regulation 2
Specified Controlled Drugs
Name of Cannabis product or preparation and brand name Dosage form Concentration of THC (percentage, weight/weight or weight/volume) Name of manufacturer Aurora High CBD Oil Drops Oral solution Less than 3% w/v (< 30mg/ml) This product also contains cannabidiol (CBD) 60% w/v (600mg/ml) Aurora Cannabis Enterprises Inc. 4439 Township Road 304, Cremona, Alberta, Canada, T0M 0R0 CannEpil ™ Oral solution 0.5% w/v (5mg/ml) This product also contains cannabidiol (CBD) 10% w/v (100mg/ml) MGC Pharmaceuticals d.o.o., Kamniška ulica 29, 1000, Ljubljana, Slovenia Tilray Oral Solution THC10:CBD10 25ml Oral solution 1% w/v (10mg/ml) This product also contains cannabidiol (CBD) 1% w/v (10mg/ml) Tilray Canada Ltd., 1100 Maughan Road, Nanaimo, BC, V9X 1J2, Canada Aurora Sedamen Softgels Capsules 5mg/capsule This product also contains cannabidiol (CBD) less than 0.2mg/capsule Aurora Cannabis Enterprises Inc. 4250 14th Avenue, Markham, Ontario, Canada L3R 0J3 ”.
3.
The following are revoked:
- (a) the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2019 ( S.I. No. 583 of 2019 ); and
- (b) the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2019.
GIVEN under my Official Seal,
29 October, 2020.
STEPHEN DONNELLY,
Minister for Health.
EXPLANATORY NOTE
(This note is not part of the Instrument and does not purport to be a legal interpretation.)
The purpose of these Regulations is to amend the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) Regulations 2019 to replace Schedule 1 in order to list certain cannabis products or preparations for medical use as “specified controlled drugs”.
These Regulations may be cited as the Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) (Amendment) Regulations 2020.
This document does not substitute the official text published in the Irish Statute Book. We accept no responsibility for any inaccuracies arising from the transcription of the original into this format.
This text is published under Irish Statute Book's own terms of reuse, not a Legalize or public-domain licence.
Irish Statute Book
CC-BY 4.0 (Oireachtas Open Data PSI Licence)
Contains Irish Public Sector Information licensed under the Oireachtas (Houses of the Oireachtas) Open Data PSI Licence / Creative Commons Attribution 4.0 International, sourced from https://www.irishstatutebook.ie.